Brief: Aadi Bioscience Announces Planned Leadership Transition

Whitehawk Therapeutics

08/11/2022 21:13

Nov 8 (Reuters) - Aadi Bioscience Inc  AADI.O :
    * AADI BIOSCIENCE ANNOUNCES PLANNED LEADERSHIP TRANSITION
    * AADI BIOSCIENCE INC- APPOINTMENT OF NEIL DESAI, FOUNDER,
PRESIDENT AND CEO TO EXECUTIVE CHAIRMAN
    * AADI BIOSCIENCE INC- BRENDAN DELANEY, CHIEF OPERATING
OFFICER,
TO PRESIDENT AND CEO, EFFECTIVE AS OF JANUARY 1, 2023

Source text for Eikon:  ID:nPn3jxgTBa 
Further company coverage:  AADI.O 
 ((Reuters.Briefs@thomsonreuters.com;))